Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Eugene R. Bleecker(Wake Forest University), J. Mark FitzGerald(Vancouver General Hospital), Pascal Chanez(Aix-Marseille Université), Alberto Papi(University of Ferrara), Steven F. Weinstein(California Allergy and Asthma Medical Group), Peter Barker(AstraZeneca (United States)), Stephanie Sproule(AstraZeneca (United States)), Geoffrey Gilmartin(AstraZeneca (United States)), Magnus Aurivillius(AstraZeneca (Sweden)), Viktoría Werkström(AstraZeneca (Sweden)), Mitchell Goldman(AstraZeneca (United States))
Cited by 1,366
Abstract
Related Papers
No related papers found
Powered by citation graph analysis